Projects

RNDr. Juraj Blaško, PhD.

International

Finished
  • Neuroprotective potential of cryopreserved placental mesenchymal stem cells (MSCs), extract, cord blood serum in the spinal cord injury (SCI).
    Program: Inter-academic agreement
    Duration: 1. 1. 2017 – 31. 12. 2019

National

Current
  • Glymphatic system and its utilization in pharmacotherapy of CNS diseases
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Mechanisms of peripheral nerve damage in chemotherapy-induced peripheral neuropathy.
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • The response of selected populations of CNS cells to peripheral nerve injury and their possible role in regeneration.
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2026
Finished
  • Neurotransmitter-mediated regulation of postnatal neurogenesis in the rat olfactory system under physiological and pathological conditions
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Analysis of peripheral nerve regeneration after transection on the model of rat caudal nerve using tubulization and mesenchymal stem cells.
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • Tubular conduits for axonal regeneration after peripheral nerve injury.
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Neuronal regulation of postnatal neurogenesis: a morphological study
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2021
  • Alternative sources of stem cells for regeneration of damaged CNS tissue
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2019
  • Axonal regeneration in biosynthetic nerve guide conduits.
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • The therapeutic effects of stem cells conditioned medium on the repair of the spinal cord damaged tissue: a comparative ex vivo study.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2018
  • Analysis of post-traumatic inflammatory and regenerative processes along the rostro-caudal axis of the spinal cord after administration of mesenchymal stem cells: an immunohistochemical and proteomic study
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Impact of angiogenesis inhibition on postnatal neurogenesis
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
Employees